Ramesh Kumar

Chief Executive Officer, Traws Pharma, Inc.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Oct 6, 2022Sold 4,500 shares at $1.83 of Ocugen3
  • Oct 6, 2022Exercised options 4,500 shares at $0.51 of Ocugen3
  • Jul 18, 2022Sold 7,500 shares at $2.57 of Ocugen4
  • Jul 18, 2022Exercised options 7,500 shares at $0.51 of Ocugen4
  • Apr 18, 2022Sold 7,500 shares at $2.83 of Ocugen5
  • Apr 18, 2022Exercised options 7,500 shares at $0.51 of Ocugen5
  • Jan 18, 2022Sold 7,500 shares at $4.07 of Ocugen6
  • Jan 18, 2022Exercised options 7,500 shares at $0.51 of Ocugen6
  • Oct 18, 2021Sold 7,500 shares at $8.13 of Ocugen7
  • Oct 18, 2021Exercised options 7,500 shares at $0.51 of Ocugen7

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7